Detroit Wayne Mental Health Authority v. Purdue Pharma L.P. et al
| Michigan Eastern District Court | |
| Judge: | Sean F Cox |
| Referred: | Stephanie Dawkins Davis |
| Case #: | 2:18-cv-13645 |
| Nature of Suit | 470 Other Statutes - Racketeer Influenced and Corrupt Organizations |
| Cause | 18:1962 Racketeering (RICO) Act |
| Case Filed: | Nov 21, 2018 |
| Terminated: | Dec 14, 2018 |
| Last checked: Monday May 20, 2019 5:44 AM EDT |
|
Defendant
Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
The Purdue Frederick Company, Inc.
|
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
|
Defendant
Teva Pharmaceutical Industries Ltd.
|
|
|
Defendant
SPECGX LLC
|
|
|
Defendant
Rhodes Pharmaceuticals L.P.
|
|
|
Defendant
Purdue Pharma L.P.
|
|
|
Defendant
Purdue Pharma Inc.
|
|
|
Defendant
Par Pharmaceutical Companies Inc.
|
|
|
Defendant
Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Noramco, Inc.
|
|
|
Defendant
McKesson Corporation
|
|
|
Defendant
Mallinckrodt PLC
|
|
|
Defendant
Mallinckrodt LLC
|
|
|
Defendant
Johnson & Johnson
|
|
|
Defendant
Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc.
|
|
|
Defendant
Insys Therapeutics, Inc.
|
|
|
Defendant
Endo Pharmaceuticals, Inc.
|
|
|
Defendant
Endo International PLC
|
|
|
Defendant
Endo Health Solutions Inc.
|
|
|
Defendant
Cephalon, Inc.
|
|
|
Defendant
Cardinal Health, Inc.
|
|
|
Defendant
Amerisourcebergen Drug Corporation
|
|
|
Defendant
Allergan PLC f/k/a Actavis PLC
|
|
|
Defendant
Allergan Finance LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.
|
|
|
Defendant
Actavis Pharma, Inc. f/k/a Watson Pharma, Inc.
|
|
|
Defendant
Actavis LLC
|
|
|
Plaintiff
Detroit Wayne Mental Health Authority
|
Represented By
|
| Docket last updated: 34 minutes ago |
| Friday, December 14, 2018 | ||
| 10 | 10
notice
Notice - Other
Fri 12/14 10:32 AM
NOTICE of Transfer to the Northern District of Ohio for MDL 2804 (SSch) |
|
| 9 | 9
order
MDL Transfer Order - Transfer Out
Fri 12/14 10:29 AM
MDL Certified Conditional Transfer Order (CTO-70) to Northern District of Ohio for MDL # 2804. (SSch) |
|
| 8 | 8
order
MDL Transfer Order - Transfer Out
Fri 12/14 10:27 AM
MDL Certified Conditional Transfer Order (CTO-70) for MDL # 2804. [Informational Copy] (SSch) |
|
|
transfer
Case Transferred Out - District
Fri 12/14 10:33 AM
Case transferred to Northern District of Ohio. (SSch) |
||
|
misc
Docket Annotation
Fri 12/14 4:05 PM
Case transferred from Michigan Eastern has been opened in Northern District of Ohio as case 1:18-op-46332, filed 12/14/2018. (VLun) |
||
| Friday, November 30, 2018 | ||
| 7 | 7
notice
Appearance
Fri 11/30 12:28 PM
NOTICE of Appearance by Dennis A. Lienhardt on behalf of All Plaintiffs. (Lienhardt, Dennis) |
|
| Wednesday, November 21, 2018 | ||
| 6 | 6
notice
Appearance
Wed 11/21 3:12 PM
NOTICE of Appearance by Sharon S. Almonrode on behalf of All Plaintiffs. (Almonrode, Sharon) |
|
| 5 | 5
trial
Exhibit
Wed 11/21 2:14 PM
EXHIBIT 91-130 re1 Complaint,,,,,,,,, by All Plaintiffs (Miller, E.) |
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 91-Iraq War Veteran,
|
||
|
Att: 3
Exhibit 92-FDA News Release,
|
||
|
Att: 4
Exhibit 93-Narcotic "Lollipop",
|
||
|
Att: 5
Exhibit 94-Cephalon, Inc.,
|
||
|
Att: 6
Exhibit 95-NDA 20-747 Letter,
|
||
|
Att: 7
Exhibit 96-Cephalon, Inc. Annual Report,
|
||
|
Att: 8
Exhibit 97-Press Release,
|
||
|
Att: 9
Exhibit 98-Cephalon Used Improper Tactics,
|
||
|
Att: 10
Exhibit 99-Transcript of Q1 2007 Cephalon, Inc,
|
||
|
Att: 11
Exhibit 100-Press Release,
|
||
|
Att: 12
Exhibit 101-FENTORA,
|
||
|
Att: 13
Exhibit 102-An Integrated Risk Evaluation and Mitigation Strategy,
|
||
|
Att: 14
Exhibit 103-Pharmacologic Management of Breakthrough,
|
||
|
Att: 15
Exhibit 104-Breakthrough Pain,
|
||
|
Att: 16
Exhibit 105-Oral Transmucosal Fentanyl Citrate for the Treatment of Migraine Headache,
|
||
|
Att: 17
Exhibit 106-Optimizing Opioid Treatment,
|
||
|
Att: 18
Exhibit 107-Opioid-Based Management,
|
||
|
Att: 19
Exhibit 108-The pain killer,
|
||
|
Att: 20
Exhibit 109-In the Matter of Insys Therapeutics, Inc.,
|
||
|
Att: 21
Exhibit 110-Doubts Raised About Off-Label Use of Subsys,
|
||
|
Att: 22
Exhibit 111-Press Release,
|
||
|
Att: 23
Exhibit 112-United States v. Babich, et al,
|
||
|
Att: 24
Exhibit 113-Opioid Billionaire Arrested,
|
||
|
Att: 25
Exhibit 114-Mallinckrodt Announces Agreement,
|
||
|
Att: 26
Exhibit 115-Pain Treatment Topics,
|
||
|
Att: 27
Exhibit 116-Oxycodone Safety Handout,
|
||
|
Att: 28
Exhibit 117-FAQs,
|
||
|
Att: 29
Exhibit 118-Commonsense Oxycodone Prescribing,
|
||
|
Att: 30
Exhibit 119-Donald Trump's Pick,
|
||
|
Att: 31
Exhibit 120-The government's struggle,
|
||
|
Att: 32
Exhibit 121-Sponsors,
|
||
|
Att: 33
Exhibit 122-Opioid Epidemic,
|
||
|
Att: 34
Exhibit 123-Red Flags,
|
||
|
Att: 35
Exhibit 124-Mallinckrodt to Pay $35M,
|
||
|
Att: 36
Exhibit 125-Press Release,
|
||
|
Att: 37
Exhibit 126-Whistleblowers,
|
||
|
Att: 38
Exhibit 127-Press Release,
|
||
|
Att: 39
Exhibit 128-AmerisourceBergen,
|
||
|
Att: 40
Exhibit 129-Drug Distribution Locations,
|
||
|
Att: 41
Exhibit 130-Drug firms poured 780M painkillers
|
||
| 4 | 4
trial
Exhibit
Wed 11/21 1:48 PM
EXHIBIT 61-90 re1 Complaint,,,,,,,,, by All Plaintiffs (Miller, E.) |
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 61-Senator McCaskill,
|
||
|
Att: 3
Exhibit 62-How big pharma got people hooked on dangerous opioids,
|
||
|
Att: 4
Exhibit 63-The Promotion and Marketing of OxyContin,
|
||
|
Att: 5
Exhibit 64-Opioid Painkiller Prescribing,
|
||
|
Att: 6
Exhibit 65-OxyContin: Purdue Pharma's Painful Medicine,
|
||
|
Att: 7
Exhibit 66-Health Q&A,
|
||
|
Att: 8
Exhibit 67-Dilaudid Addiction,
|
||
|
Att: 9
Exhibit 68-You Want a Description of Hell?,
|
||
|
Att: 10
Exhibit 69-New Hope for Millions of Americans,
|
||
|
Att: 11
Exhibit 70-In Guilty Plea,
|
||
|
Att: 12
Exhibit 71-More than 1 million OxyContin pills ended up in the hands of criminal and addicts,
|
||
|
Att: 13
Exhibit 72-Purdue Pharma agrees to restrict marketing of opioids,
|
||
|
Att: 14
Exhibit 73-Safe and Effective Opioid Rotation,
|
||
|
Att: 15
Exhibit 74-American Pain Foundation Partner Report,
|
||
|
Att: 16
Exhibit 75-Statement of United States Attorney,
|
||
|
Att: 17
Exhibit 76-NDA 19-813 Letter,
|
||
|
Att: 18
Exhibit 77-Warning Letter,
|
||
|
Att: 19
Exhibit 78-Finding Relief, Pain Management for Older Adults,
|
||
|
Att: 20
Exhibit 79-Legal Notice,
|
||
|
Att: 21
Exhibit 80-Use of Opioid Analgesics in Pain Management,
|
||
|
Att: 22
Exhibit 81-What a Prescriber Should Know,
|
||
|
Att: 23
Exhibit 82-Opana gets FDA approval,
|
||
|
Att: 24
Exhibit 83-How a Painkiller,
|
||
|
Att: 25
Exhibit 84-Outbreak of Recent HIV,
|
||
|
Att: 26
Exhibit 85-Press Release,
|
||
|
Att: 27
Exhibit 86-In the Matter of Endo Health Solutions Inc.,
|
||
|
Att: 28
Exhibit 87-Case Challenges,
|
||
|
Att: 29
Exhibit 88-Understanding Your Pain,
|
||
|
Att: 30
Exhibit 89-Resources for Education,
|
||
|
Att: 31
Exhibit 90-AboutPainKnowledge.org
|
||
| 3 | 3
service
Summons Issued*
Wed 11/21 1:40 PM
SUMMONS Issued for *Actavis LLC, Actavis Pharma, Inc. f/k/a Watson Pharma, Inc., Allergan Finance LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc., Allergan PLC f/k/a Actavis PLC, Amerisourcebergen Drug Corporation, Cardinal Health, Inc., Cephalon, Inc., Endo Health Solutions Inc., Endo International PLC, Endo Pharmaceuticals, Inc., Insys Therapeutics, Inc., Janssen Pharmaceutica, Inc. n/k/a Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt LLC, Mallinckrodt PLC, McKesson Corporation, Noramco, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. n/k/a Janssen Pharmaceuticals, Inc., Par Pharmaceutical Companies Inc., Purdue Pharma Inc., Purdue Pharma L.P., Rhodes Pharmaceuticals L.P., SPECGX LLC, Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., The Purdue Frederick Company, Inc. * (SKra) |
|
| 2 | 2
trial
Exhibit
Wed 11/21 1:29 PM
EXHIBIT 31-60 re1 Complaint,,,,,,,,, by All Plaintiffs (Miller, E.) |
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 31-A Pain-Drug Champion Has Second Thoughts,
|
||
|
Att: 3
Exhibit 32-Letter from Federation of State Medical Boards,
|
||
|
Att: 4
Exhibit 33-Pain: Current Understanding of Assessment, Management, and Treatments,
|
||
|
Att: 5
Exhibit 34-Prescription Drugs, OxyContin Abuse and Diversion and Efforts to Address the Problem,
|
||
|
Att: 6
Exhibit 35-American Pain Foundation Shuts Down,
|
||
|
Att: 7
Exhibit 36-Treatment Options:,
|
||
|
Att: 8
Exhibit 37-Episode 1: Safe Use of Opioids,
|
||
|
Att: 9
Exhibit 38-Agency for Healthcare Research and Quality,
|
||
|
Att: 10
Exhibit 39-Reducing the Risks of Relief--,
|
||
|
Att: 11
Exhibit 40-Opioid Abuse in Chronic Pain,
|
||
|
Att: 12
Exhibit 41-Pain: Opioid Facts,
|
||
|
Att: 13
Exhibit 42-A Policymaker's Guide to Understanding Pain,
|
||
|
Att: 14
Exhibit 43-Opioids for Chronic Noncancer Pain,
|
||
|
Att: 15
Exhibit 44-Patient Advocacy Group Funded by Success of Painkiller Drugs, Probe Finds,
|
||
|
Att: 16
Exhibit 45-Clinical Guidelines,
|
||
|
Att: 17
Exhibit 46-About AfPA,
|
||
|
Att: 18
Exhibit 47-Non-Profit Alliance for Patient Access,
|
||
|
Att: 19
Exhibit 48-FBI Seizes Records of Overland Park pain doctor,
|
||
|
Att: 20
Exhibit 49-Prescription Pain Medication,
|
||
|
Att: 21
Exhibit 50-Letter to Congressmen,
|
||
|
Att: 22
Exhibit 51-Ex-DEA Agent,
|
||
|
Att: 23
Exhibit 52-Current Navigation Points,
|
||
|
Att: 24
Exhibit 53-Even Amid Crisis, Opioid Makers Plied Doctors with Perks,
|
||
|
Att: 25
Exhibit 54-The Speakers' bureau system,
|
||
|
Att: 26
Exhibit 55-Speakers' Bureaus,
|
||
|
Att: 27
Exhibit 56-Two Leaders in Pain Treatment Have Long Ties to Drug Industry,
|
||
|
Att: 28
Exhibit 57-Doctor: 1,500 Pills Don't Prove Smith was Addicted,
|
||
|
Att: 29
Exhibit 58-Follow the Money,
|
||
|
Att: 30
Exhibit 59-Letter to Catherine Underwood,,
|
||
|
Att: 31
Exhibit 60-Senators Hatch and Wyden:
|
||
| 1 | 1
cmp
Civil Case - Complaint
Wed 11/21 12:52 PM
COMPLAINT filed by All Plaintiffs against All Defendants with Jury Demand. Plaintiff requests summons issued. Receipt No: 0645-6999683 - Fee: $ 400. County of 1st Plaintiff: Wayne County - County Where Action Arose: Wayne County - County of 1st Defendant: Out of State. [ Previously dismissed case: No] [ Possible companion case(s): None ] (Miller, E.) |
|
|
Att: 1
Index of Exhibits,
|
||
|
Att: 2
Exhibit 1-Prescription Drug and Opioid Abuse Task Force Releases Finding and Recommendations,
|
||
|
Att: 3
Exhibit 2-Michigan Prescription Drug and Opioid Abuse Commission,
|
||
|
Att: 4
Exhibit 3-Overdose Death Rates,
|
||
|
Att: 5
Exhibit 4-Vietnam War U.S. Military Fatal Casualty Statistics,
|
||
|
Att: 6
Exhibit 5-Increases in Drug and Opioid-Involved Overdose Deaths,
|
||
|
Att: 7
Exhibit 6-The Dizzying Increase of Overdose Deaths,
|
||
|
Att: 8
Exhibit 7-Prescription Opioid Data: Opioid Overdose,
|
||
|
Att: 9
Exhibit 8-Heroin Use and Heroin Use Risk Behaviors,
|
||
|
Att: 10
Exhibit 9-Drug Dealer, MD,
|
||
|
Att: 11
Exhibit 10-Purdue Pharma,
|
||
|
Att: 12
Exhibit 11-CDC Releases Grim New Opioid Overdose Figures,
|
||
|
Att: 13
Exhibit 12-Inside a Killer Drug Epidemic,
|
||
|
Att: 14
Exhibit 13-Drug Overdoses Now Kill More Americans Than Gun,
|
||
|
Att: 15
Exhibit 14-The Family that Built an Empire of Pain,
|
||
|
Att: 16
Exhibit 15-Attorney General Sessions Announces,
|
||
|
Att: 17
Exhibit 16-How the Opioid Epidemic Became America's Worst Drug Crisis Ever,
|
||
|
Att: 18
Exhibit 17-2nd Annual Opioid Abuse and Heroin Overdose Solution Summit,
|
||
|
Att: 19
Exhibit 18-OxyContin Goes Global,
|
||
|
Att: 20
Exhibit 19-Fueling an Epidemic, Report Two,
|
||
|
Att: 21
Exhibit 20-Systematic Review,
|
||
|
Att: 22
Exhibit 21-The Risk of a Single 5-Day Opioid Prescription,
|
||
|
Att: 23
Exhibit 22-Opioid Painkiller Prescribing Infographic,
|
||
|
Att: 24
Exhibit 23-The Prescription Opioid and Heroin Crisis,
|
||
|
Att: 25
Exhibit 24-Drug Distributors Penalized for Turning Blind Eye in Opioid Epidemic,
|
||
|
Att: 26
Exhibit 25-This One-Paragraph Letter May Have Launched the Opioid Epidemic,
|
||
|
Att: 27
Exhibit 26-A 5-Sentence Letter Helped Trigger America's Deadliest Drug Overdose Crisis Ever,
|
||
|
Att: 28
Exhibit 27-The President's Commission on Combating Drug Addiction and the Opioid Crisis,
|
||
|
Att: 29
Exhibit 28-Who is Responsible for the Pain-Pill Epidemic?,
|
||
|
Att: 30
Exhibit 29-Opioids for Chronic Pain,
|
||
|
Att: 31
Exhibit 30-AAPM Facts and Figures on Pain
|
||